NANOVIRICIDES, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Nanoviricides, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Nanoviricides, Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 27, 2024 was 14.7M shares, a 25% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 14.7M +2.93M +25% Sep 27, 2024 10-K 2024-09-27
Q1 2024 11.8M +148K +1.27% May 14, 2024 10-Q 2024-05-15
Q4 2023 11.8M +144K +1.24% Feb 14, 2024 10-Q 2024-02-14
Q3 2023 11.7M +154K +1.33% Oct 10, 2023 10-K 2023-10-13
Q1 2023 11.7M May 15, 2023 10-Q 2023-05-15
Q4 2022 11.6M +101K +0.88% Feb 14, 2023 10-Q 2023-02-14
Q3 2022 11.6M +77K +0.67% Oct 13, 2022 10-K 2022-10-13
Q2 2022 11.6M May 16, 2022 10-Q 2022-05-16
Q4 2021 11.5M Feb 14, 2022 10-Q 2022-02-14
Q3 2021 11.5M +11.5M Oct 12, 2021 10-K 2021-10-12
Q1 2021 11.5M May 14, 2021 10-Q 2021-05-14
Q3 2020 0 -76.9M -100% Aug 23, 2020 10-K 2020-10-13
Q2 2020 9.07M Jun 22, 2020 10-Q 2020-06-22
Q4 2019 7.42M -62.1M -89.3% Feb 14, 2020 10-Q 2020-02-14
Q3 2019 76.9M +7.52M +10.8% Aug 23, 2019 10-K 2019-08-23
Q1 2019 76.7M +13.4M +21.1% May 15, 2019 10-Q 2019-05-15
Q4 2018 69.5M Feb 14, 2019 10-Q 2019-02-14
Q3 2018 69.4M +6.08M +9.6% Oct 12, 2018 10-K 2018-10-12
Q2 2018 69M May 20, 2018 10-Q 2018-05-21
Q1 2018 63.4M +301K +0.48% Feb 20, 2018 10-Q 2018-02-20
Q3 2017 63.3M +5.13M +8.81% Sep 28, 2017 10-K 2017-09-28
Q1 2017 63.1M +5.1M +8.8% May 15, 2017 10-Q 2017-05-15
Q4 2016 62.8M +5M +8.64% Feb 14, 2017 10-Q 2017-02-14
Q3 2016 58.2M +940K +1.64% Sep 16, 2016 10-K 2016-09-16
Q1 2016 58M +1.41M +2.49% May 10, 2016 10-Q 2016-05-10
Q4 2015 57.8M Feb 9, 2016 10-Q 2016-02-09
Q3 2015 57.2M +789K +1.4% Sep 14, 2015 10-K 2015-09-14
Q1 2015 56.6M +2.03M +3.72% Feb 24, 2015 10-Q/A 2015-02-25
Q3 2014 56.5M +6.44M +12.9% Sep 29, 2014 10-K/A 2015-02-23
Q1 2014 54.5M -107M -66.3% May 15, 2014 10-Q 2014-05-15
Q4 2013 54M -104M -65.9% Feb 14, 2014 10-Q 2014-02-14
Q3 2013 50M -106M -67.9% Sep 30, 2013 10-K/A 2013-10-08
Q1 2013 162M May 15, 2013 10-Q/A 2013-05-20
Q4 2012 158M +6.91M +4.56% Nov 19, 2012 10-Q 2012-11-19
Q3 2012 156M +8.68M +5.9% Oct 15, 2012 10-K/A 2012-10-26
Q2 2012 155M May 17, 2012 10-Q 2012-05-21
Q4 2011 151M Feb 8, 2012 10-Q 2012-02-14
Q3 2011 147M Nov 14, 2011 10-Q/A 2011-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.